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Angiopoietin-like 4 (ANGPTL4), a secreted protein of the 
angiopoietin-like family, is induced by hypoxia in both tumor 
and endothelial cells. It is highly expressed in tumor cells from 
conventional renal carcinoma and in hypoxic perinecrotic areas of 
numerous types of human tumors (1).
We previously showed that ANGPTL4, through its action on 
both vascular and tumor cells, prevents metastastes through 
inhibition of vascular permeability as well as tumor cell motility 
and invasiveness. In vivo, using both Lewis Lung carcinoma cells 
as well as melanoma B16 cells, we showed ANGPTL4 inhibits both 
intravasation extravasation of tumor cells. Using Miles assay, 
ANGPTL4 inhibited the histamine-induced vascular permeability 
in electrotransferred mice overexpressing ANGPTL4 compared to 
control mice (2).
More recently, Padua et al. revealed a clinical association between 
TGFbeta activity in primary tumors and risk of distant recurrence, 
speci cally for estrogen receptor negative breast tumors with 
lung metastasis but not bone metastasis. In vivo, lung metastasis 
seeding from mammary tumors depends on TGFbeta receptors, 
Smad function and ANGPTL4 expression (3).
Both groups therefore report ANGPTL4 as a key regulator of 
vascular permeability. Nevertheless, better insights are needed in 
order to precisely characterize its role during tumor angiogenesis 
and subsequent metastases in various organs, namely lungs and 
bones. The aim of the present study is to address the in vivo role 
of ANGPTL4 in modulating vascular integrity, using Lewis Lung 
carcinoma cells xenografted in ANGPTL4 KO mice. Inhibition of 
tumor growth is observed in KO mice compared to WT mice (1207+/-
105 mm3 versus 3053+/-569 mm3 at day 26, p=0.002). At day 33, 
60 % of the angptl4 KO mice show large lung macrometastases 
whereas only 28 % of wild type lungs have been invaded by small 
micrometastases.
Further experiments using different metastatic models are 
ongoing in order to perform imaging analysis of blood vessels and 
endothelium integrity the during the metastatic process in angptl4 
knock-out and WT mice.
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VEGF, by stimulating endothelial cells to migrate, proliferate 
and differentiate, plays a major role in angiogenesis. Increase in 
intracellular cAMP is known to inhibit basal as well as VEGF-induced 
endothelial cell proliferation. Cyclic nucleotide phosphodiesterases 
(PDEs) play a key role in signal transduction by hydrolyzing 
speci cally cyclic nucleotides.
Our team has previously reported that PDE2 and PDE4 up-regulations 
(activity, protein and mRNA) in human umbilical vein endothelial 
cells (HUVECs) are implicated in VEGF-induced angiogenesis and 
that inhibition of PDE2 and PDE4 isozyme activities prevents the 
development of angiogenesis by increasing cAMP level, by inhibiting 
cell proliferation, cell migration and cell cycle progression (Favot et 
al., Thromb Haemost 2003, 90: 334 and 2004, 92: 634). On another 
hand, we have shown that polyphenols inhibit PDEs (Orallo et al., 
Naunyn Schmiedebergs Arch Pharmacol 2004, 370: 452 ; Planta Med 
2005, 71: 99 ; Alvarez et al., Br J Pharmacol. 2006, 147: 269).
The polyphenol curcumin, isolated from the plant Curcuma longa, 
is present in curry powder, and is known to have anti-in ammatory, 
anti-oxidant and anti-cancer properties. The anti-carcinogenic 
properties of curcumin have been demonstrated in animals by its 
ability to inhibit tumor initiation and tumor progression. Therefore, 
this study was aimed to investigate the participation of PDEs in 
anti-angiogenic properties of curcumin.
The effect of curcumin on PDE activities was assessed by the 
determination of IC50 values on the  ve isozymes PDE1-PDE5 
puri ed from vascular tissues. Curcumin was able to inhibit PDE1, 
PDE2, PDE3 and PDE4 with IC50 values in the range of 10 to 20 m, 
and PDE5 with an IC50 value of 35 m.
Curcumin at a concentration of 10 m inhibited both basal and 
VEGF-stimulated HUVEC proliferation (58 % and 54 % respectively, 
P=0.003). Furthermore, 10 m curcumin inhibited signi cantly 
(52 %, P=0.001) VEGF-induced HUVEC migration similarly to the 
selective PDE2 inhibitor (0.1 m BAY-60-7550, 69 %, P=0.003) and 
the selective PDE4 inhibitor (10 m rolipram, 41 %, P=0.006)).
These results, showing for the  rst time that curcumin inhibits 
PDE activities, suggest that curcumin present in food might inhibit 
angiogenesis at endothelial cell level by inhibiting PDE activities.
